Protein misfolding
and aggregation have attracted immense research
interests due to their connection with an array of degenerative diseases
including neurodegenerative disorders and non-neuropathic diseases.
Inhibition or diminution of the formation of protein aggregates is
considered as a potential therapeutic strategy to cure these debilitating
maladies. A large number of compounds including flavonoids, surfactants,
osmolytes, vitamins, nanoparticles, etc. have been explored for impeding
protein aggregation process and ameliorating neurodegenerative disorders.
Even though a plethora of strategies have been designed to suppress
protein aggregation, the final success rate is limited due to the
lack of in-depth understanding of the aggregation pathway. In this
context, polymeric materials are attracting the attention of researchers
owing to their multifarious applications in the field of biomedical
science and technology, and their unique properties as many parameters
like functionality, molecular weight, architecture, etc. can be easily
manipulated to improve their efficacy as well as meet clinical requirements.
This review article highlights an outline of protein misfolding and
aggregation, their mechanistic pathway, the factors responsible for
aggregation, and potential therapeutic strategies for the intervention
of those debilitating pathological conditions. Especially, the primary
focus of this review article is to delineate the obligatory role of
polymeric materials on protein aggregation pathway and encourage researchers
to fabricate effective polymeric materials for designing next generation
antiamyloidogenic therapeutic agents.